Rosmantuzumab: A Deep Dive into OMP-131R10 Rosmantuzumab, previously known through OMP-131R10, represents a new monoclonal antibody engineered to target granulocyte-macrophage colony-stimulating GM-CSF. Its mode of https://www.targetmol.com/compound/rosmantuzumab